In combination with corroborative findings by other studies examining the role of TSP-1 and metabolic dysfunction mediated fibrosis [18, 19, 23–25], our study suggests that TSP-1 may be an attractive target for NASH-induced hepatic fibrosis. This evidence concerns the gene THBS1 and metabolic dysfunction-associated steatohepatitis.